Vault-13

Column Group LLC

San Francisco, CA · CIK 1833486 · 13F filing filed 2022-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$469.9m reported value -12.9% vs Q1 2022
7positions
100.0%in top 10
0 new 3 added 1 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NGM BIOPHARMACEUTICALS INC COM NGM NGM 18,136,735 $232.5m49.49% 49.49% AddedShares held: Q3 2021 15.4m, Q4 2021 15.4m, Q1 2022 16.2m, Q2 2022 18.1m +1.9m +1,890,918 11.6%
2 REVOLUTION MEDICINES INC COM RVMD RVMD 4,395,050 $85.7m18.23% 18.23% AddedShares held: Q3 2021 3.3m, Q4 2021 3.3m, Q1 2022 3.3m, Q2 2022 4.4m +1.0m +1,047,805 31.3%
3 TENAYA THERAPEUTICS INC COM TNYA TNYA 9,400,290 $52.9m11.26% 11.26% UnchangedShares held: Q3 2021 9.4m, Q4 2021 9.4m, Q1 2022 9.4m, Q2 2022 9.4m
4 RAPT THERAPEUTICS INC COM COM 2,680,458 $48.9m10.41% 10.41% AddedShares held: Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 2.7m +1.3m +1,278,450 91.2%
5 SURROZEN INC COM COM 9,248,129 $27.7m5.90% 5.90% ReducedShares held: Q3 2021 9.2m, Q4 2021 9.4m, Q1 2022 9.4m, Q2 2022 9.2m -166.7k -166,666 -1.8%
6 ORIC PHARMACEUTICALS INC COM ORIC ORIC 3,568,181 $16.0m3.40% 3.40% UnchangedShares held: Q3 2021 4.8m, Q4 2021 3.6m, Q1 2022 3.6m, Q2 2022 3.6m
7 EFFECTOR THERAPEUTICS INC COM COM 4,309,329 $6.1m1.30% 1.30% UnchangedShares held: Q3 2021 4.3m, Q4 2021 4.3m, Q1 2022 4.3m, Q2 2022 4.3m